Commodore Capital’s VistaGen Therapeutics VTGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.15M | Hold |
1,575,000
| – | – | 0.22% | 32 |
|
|
2025
Q1 | $3.94M | Hold |
1,575,000
| – | – | 0.29% | 30 |
|
|
2024
Q4 | $4.65M | Hold |
1,575,000
| – | – | 0.34% | 28 |
|
|
2024
Q3 | $4.74M | Hold |
1,575,000
| – | – | 0.3% | 35 |
|
|
2024
Q2 | $5.48M | Hold |
1,575,000
| – | – | 0.37% | 31 |
|
|
2024
Q1 | $8.32M | Hold |
1,575,000
| – | – | 0.56% | 32 |
|
|
2023
Q4 | $8.1M | Hold |
1,575,000
| – | – | 0.71% | 27 |
|
|
2023
Q3 | $8.25M | Buy |
+1,575,000
| New | +$8.25M | 0.96% | 25 |
|
|
2022
Q3 | – | Sell |
-434,969
| Closed | -$11.5M | – | 33 |
|
|
2022
Q2 | $11.5M | Buy |
434,969
+98,395
| +29% | +$2.6M | 2.43% | 15 |
|
|
2022
Q1 | $12.5M | Buy |
336,574
+54,407
| +19% | +$2.02M | 2.8% | 13 |
|
|
2021
Q4 | $16.5M | Buy |
282,167
+111,383
| +65% | +$6.52M | 3.82% | 12 |
|
|
2021
Q3 | $14M | Buy |
170,784
+59,740
| +54% | +$4.91M | 3.7% | 12 |
|
|
2021
Q2 | $10.5M | Sell |
111,044
-13,279
| -11% | -$1.25M | 3.66% | 13 |
|
|
2021
Q1 | $7.94M | Buy |
124,323
+19,323
| +18% | +$1.23M | 3.16% | 13 |
|
|
2020
Q4 | $6.11M | Buy |
+105,000
| New | +$6.11M | 3.32% | 16 |
|